Cerus Endovascular Company Overview, Contact Details & Competitors

Q: What is Cerus Endovascular's official website and social media links?

Cerus Endovascular's official website is cerusendo.com. Cerus Endovascular has social profiles on LinkedIn.

Q: How many employees does Cerus Endovascular have currently?

Cerus Endovascular has approximately 11 employees.

Q: What technology does Cerus Endovascular use?

Cerus Endovascular's tech stack includes Google Fonts API, RequireJS, React, Webpack, Zepto.

Insights

Gathering insights about Cerus Endovascular…

Similar companies to Cerus Endovascular

Cerus Endovascular Tech Stack

Cerus Endovascular uses 7 technology products and services including Webpack, DreamWeaver, Google Fonts API, and more. Explore Cerus Endovascular's tech stack below.

Webpack
Development
DreamWeaver
Editors
Google Fonts API
Font Scripts
RequireJS
Javascript Frameworks
React
Javascript Frameworks
TweenMax
Javascript Frameworks
Zepto
Javascript Libraries

Media & News

Stryker acquired Cerusendo on May 1st '23.
Stryker is acquiring Cerus Endovascular, a private medical device company that designs neurointerventional devices to treat intracranial aneurysms.
May 01, 2023 | www.dotmed.com
Cerusendo launched FDA 510 on Mar 23rd '22.
Cerus Endovascular this week announced the FDA 510(k) clearance of its 027 microcatheters.
Mar 23, 2022 | www.massdevice.com
Cerusendo receives financing of $19M in Series B.
US-based privately held commercial-stage medical device company Cerus Endovascular has raised $19m in a Series B financing from institutional investors.
Feb 24, 2020 | www.medicaldevice-network.com
Cerusendo launched patients in the CERUS Study on Nov 13th '18.
Cerus Endovascular Ltd., a privately held medical device company engaged in developing interventional neuroradiology devices and delivery systems to treat acute, life-threatening intracranial aneurysms, today announced enrollment of the first patients in the CERUS Study ( C ontour Neurovascular System E uropean Pre-Ma r ket U nruptured Aneurysm S tudy).
Nov 13, 2018 | www.prnewswire.com
Cerusendo hired John Kilcoyne as board of directors on Sep 18th '18.
Cerus Endovascular Ltd., a privately held, commercial-stage medical device company engaged in the design and development of highly differentiated and proprietary interventional neuroradiology devices and delivery systems to treat acute, life-threatening intracranial aneurysm, today announced it has appointed John Kilcoyne to its board of directors, effective immediately.
Sep 18, 2018 | www.prnewswire.com

Cerus Endovascular's Email Address Formats

Cerus Endovascular uses at least 1 format(s):

Cerus Endovascular Email Formats	Example	Percentage
First.Last@cerusendo.com	John.Doe@cerusendo.com	50%
First.Last@cerusendo.com	John.Doe@cerusendo.com	50%

Frequently Asked Questions

Where is Cerus Endovascular's headquarters located?

Cerus Endovascular's main headquarters is located at John Eccles HOuse Oxford, Select State OX44GP gb. The company has employees across 3 continents, including EuropeNorth AmericaSouth America.

What is Cerus Endovascular's phone number?

You can contact Cerus Endovascular's main corporate office by phone at

+1-510-651-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cerus Endovascular's official website and social media links?

Cerus Endovascular's official website is cerusendo.com and has social profiles on LinkedIn.

What is Cerus Endovascular's NAICS code?

Cerus Endovascular's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Cerus Endovascular have currently?

As of July 2025, Cerus Endovascular has approximately 11 employees across 3 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Financial Officer: D. J.Founder, Executive Chairman & CEO: J. T. D.Clinical Sales Director: N. M.. Explore Cerus Endovascular's employee directory with LeadIQ.

What industry does Cerus Endovascular belong to?

Cerus Endovascular operates in the Medical Equipment Manufacturing industry.

What technology does Cerus Endovascular use?

Cerus Endovascular's tech stack includes WebpackDreamWeaverGoogle Fonts APIRequireJSReactTweenMaxZepto.

What is Cerus Endovascular's email format?

Cerus Endovascular's email format typically follows the pattern of First.Last@cerusendo.com. Find more Cerus Endovascular email formats with LeadIQ.

How much funding has Cerus Endovascular raised to date?

As of July 2025, Cerus Endovascular has raised $19M in funding. .

Insights

Similar companies to Cerus Endovascular

BIOTRONIK

MagVenture

CardioFocus

Medtronic

Biosense Webster

Imricor

Siemens Healthineers

Boston Scientific

Cerus Endovascular Tech Stack

Media & News

Stryker acquired Cerusendo on May 1st '23.

Cerusendo launched FDA 510 on Mar 23rd '22.

Cerusendo receives financing of $19M in Series B.

Cerusendo launched patients in the CERUS Study on Nov 13th '18.

Cerusendo hired John Kilcoyne as board of directors on Sep 18th '18.

Cerus Endovascular's Email Address Formats

Frequently Asked Questions

Where is Cerus Endovascular's headquarters located?

What is Cerus Endovascular's phone number?

What is Cerus Endovascular's official website and social media links?

What is Cerus Endovascular's NAICS code?

How many employees does Cerus Endovascular have currently?

What industry does Cerus Endovascular belong to?

What technology does Cerus Endovascular use?

What is Cerus Endovascular's email format?

How much funding has Cerus Endovascular raised to date?

Cerus Endovascular

Company Overview

Media & News

Stryker acquired Cerusendo on May 1st '23.

Cerusendo launched FDA 510 on Mar 23rd '22.

Cerusendo receives financing of $19M in Series B.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?